Renal tumors in the Birt-Hogg-Dubé syndrome

American Journal of Surgical Pathology

Volumn 26, Issue 12, 2002, Pages 1542-1552

  Pavlovich, Christian P ^a   Walther, McClellan M ^a   Eyler, Robin A ^a   Hewitt, Stephen M ^a   Zbar, Berton ^a   Linehan, W Marston ^a   Merino, Maria J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Birt Hogg Dub syndrome; Chromophobe renal cell carcinoma; Clear cell (conventional) renal cell carcinoma; Kidney cancer; Oncocytosis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BIRT HOGG DUBE SYNDROME; CANCER RISK; CANCER SURGERY; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FACE; FEMALE; GENODERMATOSIS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; NECK; ONCOCYTOMA; PAPULE; PATHOLOGICAL ANATOMY; PNEUMOTHORAX; PREOPERATIVE PERIOD; SYNDROME DELINEATION; TRUNK; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADENOMA, OXYPHILIC; ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOME DISORDERS; DNA, NEOPLASM; FEMALE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; SEQUENCE ANALYSIS, DNA; SKIN DISEASES, GENETIC; SYNDROME;

EID: 0036892633     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200212000-00002     Document Type: Article

References (39)

1. Akhtar M, Kardar H, Linjawi T, et al. Chromophobe cell carcinoma of the kidney: A clinicopathologic study of 21 cases. Am J Surg Pathol 1995;19:1245-56.
2. Birt AR, Hogg GR, Dubé WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977;113:1674-7.
3. Brauch H, Pomer S, Hieronymus T, et al. Genetic alterations in sporadic renal-cell carcinoma: Molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p. World J Urol 1994;12:162-8.
4. Cawkwell L, Bell SM, Lewis FA, et al. Rapid detection of allele loss in colorectal tumors using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-7.
5. Cheadle JP, Reeve MP, Sampson JR, et al. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000;107:97-114.
6. Clifford SC, Cockman ME, Smallwood AC, et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumorigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001;10:1029-38.
7. Coppes MJ, Egeler RM. Genetics of Wilms' tumor. Semin Urol Oncol 1999;17:2-10.
8. Foster K, Crossey PA, Cairns P, et al. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 1994;69:230-4.
9. Foster K, Prowse A, van den Berg A, et al. Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in nonfamilial clear cell renal carcinoma. Hum Mol Genet 1994;3:2169-73.
10. Gnarra JR, Tory K, Weng Y, et al. Mutation of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 1994;7:85-90.
11. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
12. Kandt RS, Haines JL, Smith M, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41.
13. Kenck C, Wilhelm M, Bugert P, et al. Mutation of the VHL gene is associated exclusively with the development of nonpapillary renal cell carcinomas. J Pathol 1996;179:157-61.
14. Knudson AG. Chasing the cancer demon. Annu Rev Genet 2000;34:1-19.
15. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumors. J Pathol 1997;183:131-3.
16. Krishnan B, Truong LD. Renal epithelial neoplasms: The diagnostic implications of electron microscopic study in 55 cases. Hum Pathol 2002;33:68-79.
17. Latif F, Tory K, Gnarra JR, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
18. Linehan WM, Zbar B, Klausner RD. Renal carcinoma. In; Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:907-29.
19. Ornstein DK, Lubensky IA, Venzon D, et al. Prevalence of microscopic tumors in normal appearing renal parenchyma from patients with hereditary papillary renal cancer. J Urol 2000;163:431-3.
20. Poston CD, Jaffe GS, Lubensky IA, et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: Clinical and molecular genetic implications. J Urol 1995;153:22-6.
21. Roth JS, Rabinowitz AD, Benson M, et al. Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol 1993;29:1055-6.
22. Schmidt L, Duh F-M, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997;16:68-73.
23. Schmidt LS, Warren MB, Nickerson ML, et al. Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001;69:876-82.
24. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994;54:2852-5.
25. Stolle CA, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998;12:417-23.
26. Störkel S, Pannen B, Thoenes W, et al. Intercalated cells as a probable source for the development of renal oncocytoma. Virchows Arch B Cell Pathol Mol Pathol 1988;56:185-9.
27. Störkel S, Steart PV, Drenckhahn D, et al. The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Mol Pathol 1989;56:237-45.
28. Störkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: Workgroup no. 1. Cancer 1997;80:987-9.
29. Takahashi A, Hayashi T, Yoshida O, et al. Renal cell carcinoma in the Birt-Hogg-Dubé syndrome: Report of a case. Hinyokika Kiyo 2001;47:719-21.
30. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: Emphasis on technique and patterns of staining. Am J Surg Pathol 1998;22:419-24.
31. Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: A morphologic study of fourteen cases. Am J Surg Pathol 1999;23:1094-101.
32. Toro J, Duray PH, Glenn GM, et al. Birt-Hogg-Dubé syndrome: A novel marker of kidney neoplasia. Arch Dermatol 1999;135:1195-202.
33. van den Berg A, Hulsbeek MF, de Jong D, et al. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes Cancer 1996;15:64-72.
34. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8.
35. Walther MM, Lubensky IA, Venzon D, et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: Clinical implications. J Urol 1995;154:2010-5.
36. Weirich G, Glenn G, Junker K, et al. Familial renal oncocytoma: Clinicopathologic study of 5 families. J Urol 1998;160:335-40.
37. Weirich G, Junker K, Salles PGO, et al. Comparative genomic hybridization analysis of renal oncocytomas (RO), chromophobe renal cell carcinomas (CHRCC), and tumors with hybrid histology: Hybrid oncocytic tumors (HOT) [Abstract]. Mod Pathol 2002;15:186.
38. Whaley JM, Naglich J, Gelbert L, et al. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994;55:1092-102.
39. Zbar B, Alvord G, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:393-400.